KPTI
Karyopharm Therapeutics Inc
Price:  
1.10 
USD
Volume:  
2,022,240.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KPTI WACC - Weighted Average Cost of Capital

The WACC of Karyopharm Therapeutics Inc (KPTI) is 6.9%.

The Cost of Equity of Karyopharm Therapeutics Inc (KPTI) is 10.65%.
The Cost of Debt of Karyopharm Therapeutics Inc (KPTI) is 5.50%.

Range Selected
Cost of equity 9.10% - 12.20% 10.65%
Tax rate 0.20% - 0.20% 0.20%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.4% - 8.4% 6.9%
WACC

KPTI WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.14 1.3
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.10% 12.20%
Tax rate 0.20% 0.20%
Debt/Equity ratio 2.64 2.64
Cost of debt 4.00% 7.00%
After-tax WACC 5.4% 8.4%
Selected WACC 6.9%